Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Progyny (PGNY)
NASDAQ:PGNY
Holding PGNY?
Track your performance easily
PGNY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$13.39 - $42.08
Previous Close$14.61
Volume2.07M
Average Volume (3M)2.26M
Market Cap
$1.24B
Enterprise Value$1.02B
Total Cash (Recent Filing)$235.72M
Total Debt (Recent Filing)$16.63M
Price to Earnings (P/E)25.2
Beta1.38
Next Earnings
Mar 03, 2025EPS Estimate
$0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.58
Shares Outstanding85,153,267
10 Day Avg. Volume1,382,820
30 Day Avg. Volume2,259,892
Standard Deviation0.15
R-Squared0.24
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.86
Price to Sales (P/S)1.09
Price to Cash Flow (P/CF)7.00
P/FCF Ratio7.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.90
Enterprise Value/Gross Profit4.29
Enterprise Value/Ebitda17.69
Forecast
1Y Price Target
$18.63Price Target Upside25.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Progyny News
PremiumCompany Announcements
Progyny, Inc. Reports Steady Growth Amid Strategic Wins
Bulls Say, Bears Say
Bulls Say
Client GrowthProgyny's strong selling season resulted in the addition of 80 new clients and 1.1 million new lives, illustrating robust demand for fertility benefits.
Client RetentionProgyny maintains a high client retention rate of 99%, showcasing strong customer satisfaction and loyalty despite competitive market pressures.
Market ExpansionProgyny's diversified service offerings, including maternity and menopause care, have attracted 1.5 million lives for 2025, highlighting the company's successful market expansion.
Bears Say
Attrition And Competitive LandscapeThe recent attrition of five customers, including a major client, has raised investor questions about the competitive landscape, with these concerns likely remaining unresolved until the next selling season.
Financial Performance And GuidancePGNY's 2024 annual guidance was lowered due to the third quarter miss, with expectations now set for no improvement in ART cycles, reflecting ongoing challenges in meeting revenue and adjusted EBITDA targets.
Utilization And Revenue VolatilityContinued unexplained utilization volatility is likely to keep pressuring the stock, with no clear timeline for improvement and ongoing uncertainty affecting the business model.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PGNY FAQ
What was Progyny’s price range in the past 12 months?
Progyny lowest stock price was $13.39 and its highest was $42.08 in the past 12 months.
What is Progyny’s market cap?
Currently, no data Available
When is Progyny’s upcoming earnings report date?
Progyny’s upcoming earnings report date is Mar 03, 2025 which is in 72 days.
How were Progyny’s earnings last quarter?
Progyny released its earnings results on Nov 12, 2024. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.143 by -$0.033.
Is Progyny overvalued?
According to Wall Street analysts Progyny’s price is currently Undervalued.
Does Progyny pay dividends?
Progyny does not currently pay dividends.
What is Progyny’s EPS estimate?
Progyny’s EPS estimate is $0.09.
How many shares outstanding does Progyny have?
Progyny has 85,153,270 shares outstanding.
What happened to Progyny’s price movement after its last earnings report?
Progyny reported an EPS of $0.11 in its last earnings report, missing expectations of $0.143. Following the earnings report the stock price went down -19.092%.
Which hedge fund is a major shareholder of Progyny?
Among the largest hedge funds holding Progyny’s share is Farallon Capital Management, L.L.C.. It holds Progyny’s shares valued at 16M.
---
Progyny Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.63 (25.12% Upside)
$18.63 (25.12% Upside)
Blogger Sentiment
Bullish
PGNY Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 227.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 7.4%
Last 30 Days ▼ 7.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.55%
12-Months-Change
Fundamentals
Return on Equity
12.05%
Trailing 12-Months
Asset Growth
-9.16%
Trailing 12-Months
Company Description
Progyny
Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
---
PGNY Earnings Call
Q3 2024
0:00 / 0:00
---
PGNY Stock 12 Month Forecast
Average Price Target
$18.63
▲(25.12% Upside)
Technical Analysis
Best Analysts Covering PGNY
1 Year
1 Year Success Rate
5/12 ratings generated profit
1 Year Average Return
+1.21%
reiterated a buy rating last month
Copying Glen Santangelo's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +1.21% per trade.
---